William Garvin focuses his practice on issues related to the approval, regulation, promotion, sale, and reimbursement of drugs, medical devices, biologics, cannabis products, excipients, dietary supplements, and foods.William assists clients in their interactions with various federal agencies including: Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), Drug Enforcement Agency (DEA), Federal Trade Commission (FTC), and Health and Human Services (HHS). William's work includes challenging administrative agency actions through correspondence, citizen petitions, and litigation. He has extensive experience in assisting companies with complying and contesting administrative agency actions and regulations at both the federal and state level.